My bookmarksSign up free

2005/464/EC: Commission Decision of 21 June 2005 on the implementation of survey programmes for avian influenza in poultry and wild birds to be carried out in the Member States (notified under document number C(2005) 1827) Text with EEA relevance

2005/464/EC: Commission Decision of 21 June 2005 on the implementation of survey programmes for avian influenza in poultry and wild birds to be carried out in the Member States (notified under document number C(2005) 1827) Text with EEA relevance

Decision · 5 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

By 30 June 2005, Member States shall submit for approval to the Commission programmes for the implementation of surveys for avian influenza in poultry and wild birds in accordance with the Annex.

Article 2

The Community’s financial contribution towards the measures provided for in Article 1 shall be at the rate of 50 % of the costs incurred in Member States up to a maximum of EUR 1 200 000 for the Member States in total.

Article 3

The maximum amounts of the testing costs to be reimbursed shall not exceed: (a) ELISA test : EUR 1 per test; (b) agar gel immune diffusion test : EUR 0,6 per test; (c) HI test for H5/H7 : EUR 4 per test; (d) virus isolation test : EUR 30 per test.

Article 4

This Decision is addressed to the Member States.

Supplementary provisions

ANNEXSupplementary provisions

ANNEX Programmes for surveillance of avian influenza in poultry and wild birds to be carried out in the Member States in 2005 and 2006 A.   OBJECTIVES 1. To estimate the prevalence of infections with avian influenza virus subtypes H5 and H7 in different species of poultry by repeating previous screening exercises provided for in Decisions 2004/111/EC and 2004/630/EC in a modified, more targeted manner. 2. To continue surveillance for avian influenza on a voluntary basis in wild birds. The outcome of such surveillance should further provide valuable information for an early warning system of strains that may be introduced into poultry flocks from wild birds. 3. To contribute to the knowledge on the threats of avian influenza to animal health from wildlife. 4. To foster the connection and integration of human and veterinary networks for influenza surveillance. B.   GENERAL REQUIREMENTS AND CRITERIA FOR SURVEYS IN POULTRY 1. Sampling shall cover a period appropriate to production periods for each poultry category as required. For example, in many Member States a large slaughter of poultry (in particular turkeys and geese) takes place around Christmas. Sampling shall not extend beyond 31 January 2006. 2. 31 March 2006 shall be the date for the submission of the final survey results. 3. Testing of samples shall be carried out at national laboratories for avian influenza (NL) in Member States or by other laboratories authorised by the competent authorities and under the control of the NL. 4. All results (both serological and virological) shall be sent to the Community Reference Laboratory (CRL) for collation. A good flow of information must be ensured. The CRL shall provide technical support and keep an enlarged stock of diagnostic reagents. Antigens for use in the survey shall be supplied to NL’s by the CRL to ensure uniformity. 5. All avian influenza (AI) virus isolates shall be submitted to the CRL in accordance with Community legislation. Viruses of H5/H7 subtype shall be submitted without delay and shall be subjected to the standard characterisation tests (nucleotide sequencing/IVPI) according to Directive 92/40/EEC. In addition, the CRL shall require that H5 or H7 positive sera collected from anseriformes be submitted ‘blind’ in order that an archive be established to facilitate future test development. 6. All positive findings shall be retrospectively investigated at the holding and the conclusions of this investigation shall be reported to the Commission and the CRL. 7. Specific protocols to accompany the sending of material to the CRL and reporting tables for collection of survey data shall be provided by the CRL. In those tables the laboratory testing methods used shall be indicated. The tables provided shall be used to submit results in a single document. 8. Blood samples for serological examination shall be collected from all species of poultry including those reared in free-range systems, from at least 5 to 10 birds (except ducks geese and quail) per holding, and from the different sheds, if more than one shed is present on a holding. 9. Sampling shall be stratified throughout the territory of the whole Member State, so that samples can be considered as representative for the whole of the Member State, taking into account: (a) the number of holdings to be sampled (excluding ducks, geese and turkeys); that number shall be defined so as to ensure the identification of at least one infected holding if the prevalence of infected holdings is at least 5 %, with a 95 % confidence interval; (see table 1) and (b) the number of birds sampled from each holding shall be defined so as to ensure 95 % probability of identifying at least one positive bird if the prevalence of sero-positive birds is ≥ 30 %. 10. The sampling design shall also consider: (a) The types of production and their specific risks, shall be targeted to free range production and outdoor keeping plus taking into account other factors such as multi-age, use of surface water, a relatively longer life span, the presence of more than one species on the holding or other relevant factors. (b) The number of turkey, duck and goose holdings to be sampled shall be defined to ensure the identification of at least one infected holding if the prevalence of infected holdings is at least 5 %, with a 99 % confidence interval (see table 2). (c) Where significant number of holdings producing ratites and quails are present in a Member State they shall be included in the programme. With regard to quails only adult (or laying) breeders shall be sampled. (d) The time period for sampling shall coincide with seasonal production. However, where appropriate, sampling can be adapted to other identified periods at local level, during which time the presence of other poultry hosts on a holding might pose a greater risk for disease introduction. (e) Member States that must carry out sampling for Newcastle disease to maintain their status as Newcastle disease non-vaccinating countries in accordance with Commission Decision 94/327/EC  ( 1 ) may utilise these samples from breeding flocks for the surveillance of H5/H7 antibodies. Table 1 Number of holdings to be sampled of each poultry category (except turkey, duck and goose holdings) Number of holdings per poultry category per Member State Number of holdings to be sampled Up to 34 All 35-50 35 51-80 42 81-250 53 > 250 60 Table 2 Number of turkey, duck and goose holdings to be sampled Number of holdings per Member State Number of holdings to be sampled Up to 46 All 47-60 47 61-100 59 101-350 80 > 350 90 C.   SPECIFIC REQUIREMENTS FOR DETECTION OF INFECTIONS WITH H5/H7 SUBTYPES OF AVIAN INFLUENZA IN DUCKS, GOOSE AND QUAIL 1. Blood samples for serological testing shall be taken preferably from birds which are kept outside in fields. 2. From each selected holding 40 to 50 blood samples shall be taken for serological testing. D.   SURVEY FOR AVIAN INFLUENZA IN WILD BIRDS In those Member States where surveillance will also concern wild birds the following guidelines shall be followed. D.1.   Survey design and implementation 1. Liaisons with bird conservation/watching institutions and ringing stations are necessary. Sampling where appropriate shall be carried out by staff from these groups/stations or by hunters. 2. Experience with the previous surveys has shown that the virus isolation rate was extremely low, therefore sampling shall focus on the birds migrating south during autumn and early winter. D.2.   Sampling procedures 1. Cloacal swabs for virological examination shall be taken. In addition to ‘first year’ birds in autumn, host species with high susceptibility and increased contact with poultry (such as Mallard ducks) may offer the highest chance of success. 2. Samples shall be taken from different species of free living birds. Waterfowl and shorebirds shall be the main sampling targets. 3. Swabs containing faeces, or carefully collected fresh faeces shall be taken from wild birds trapped, hunted and found freshly dead. 4. Pooling of up to five samples from the same species is possible. Specific care has to be taken for the storage and transport of samples. If rapid transport within 48 hours to the laboratory (in transport medium at 4° Celsius) is not guaranteed, samples shall be stored and then transported in dry ice at – 70° Celsius. E.   LABORATORY TESTING Laboratory tests shall be carried out in accordance with the diagnostic procedures for the confirmation and differential diagnostic of avian influenza (AI) set out in Annex III to Directive 92/40/EEC (including examination of sera from ducks and geese by haemagglutination-inhibition (HI) test. However, if laboratory tests not laid down in Directive 92/40/EEC, nor described in the OIE Terrestrial Manual, are envisaged, Member States shall provide the necessary validation data to the CRL, in parallel to submitting their programme to the Commission for approval. All positive serological findings shall be confirmed by the National laboratories for avian influenza by an haemagglutination-inhibition test, using designated strains supplied by the Community Reference Laboratory: H5 (a) Initial test using Duck/Denmark/64650/03 (H5N7) (b) Test all positives with Ostrich/Denmark/72420/96 (H5N2) to eliminate N7 cross reactive antibody. H7 (a) Initial test using Turkey/England/647/77 (H7N7) (b) Test all positives with African Starling/983/79 (H7N1) to eliminate N7 cross reactive antibody. ( 1 )    OJ L 146, 11.6.1994, p. 17 .

Other acts of the same type
Council Decision (CFSP) 2023/1188 of 19 June 2023 amending Decision 2014/386/CFSP concerning restrictive measures in response to the illegal annexation of Crimea and SevastopolCouncil Implementing Decision (CFSP) 2023/1189 of 19 June 2023 implementing Decision 2010/788/CFSP concerning restrictive measures in view of the situation in the Democratic Republic of the CongoCouncil Decision (EU) 2023/1196 of 16 June 2023 amending Decision 1999/70/EC concerning the external auditors of the national central banks, as regards the external auditors of the Bank Ċentrali ta’ Malta/Central Bank of MaltaCommission Implementing Decision (EU) 2023/1336 of 16 June 2023 on corrective measures to be taken by Belgium and Luxembourg regarding certain performance targets for the third reference period in accordance with Regulation (EC) No 549/2004 of the European Parliament and of the Council (notified under document C(2023)3852) Only the Dutch and French texts are authentic (Text with EEA relevance)Decision (EU) 2023/1165 of the European Parliament and of the Council of 14 June 2023 amending Decision (EU) 2022/563 as regards the amount of macro-financial assistance to the Republic of MoldovaCouncil Implementing Decision (CFSP) 2023/1148 of 12 June 2023 implementing Decision 2010/231/CFSP concerning restrictive measures against SomaliaCouncil Decision (EU) 2024/1253 of 12 June 2023 on the position to be taken on behalf of the European Union in the World Forum for Harmonization of Vehicle Regulations of the United Nations Economic Commission for Europe on proposals for modifications to UN regulation Nos 13, 16, 24, 41, 49, 51, 54, 75, 78, 79, 83, 85, 94, 95, 101, 109, 110, 117, 127, 129, 134, 135, 137, 153 and 155, on a proposal for a new UN regulation on global real driving emissions, on a proposal for a modification to UN GTR No 13, and on a proposal for a new UN GTR on laboratory measurement of brake emissions for light-duty vehiclesCommission Implementing Decision (EU) 2023/1155 of 9 June 2023 on the unresolved objections regarding the terms and conditions of the authorisation of the biocidal product Rapid Pro referred by France in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (notified under document C(2023) 3666) (Text with EEA relevance)Commission Implementing Decision (EU) 2023/1156 of 9 June 2023 authorising grading methods for the classification of pig carcasses in Slovakia and repealing Decision 2009/622/EC (notified under document C(2023) 3684) (Only the Slovak text is authentic)Commission Implementing Decision (EU) 2023/1157 of 9 June 2023 on the unresolved objections regarding the terms and conditions of the authorisation of the biocidal product Virazan referred by France in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (notified under document C(2023) 3710) (Text with EEA relevance)Council Decision (CFSP) 2024/226 of 9 June 2023 on the signing and conclusion of the Agreement between the European Union and the Government of the Islamic Republic of Mauritania on the establishment and functioning of the European Union Regional Advisory and Coordination Cell deployed in Nouakchott to support the G5 Sahel structuresCouncil Decision (CFSP) 2023/1138 of 8 June 2023 amending Decision (CFSP) 2016/1693 concerning restrictive measures against ISIL (Da’esh) and Al-Qaeda and persons, groups, undertakings and entities associated with them

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

What to look at next